PAGS | ||
---|---|---|
OUTLOOK RATING 1..100 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 54 | |
PRICE GROWTH RATING 1..100 | 57 | |
P/E GROWTH RATING 1..100 | 90 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FLN | PAGS | |
---|---|---|
RSI ODDS (%) | 1 day ago77% | 1 day ago81% |
Stochastic ODDS (%) | 1 day ago80% | 1 day ago78% |
Momentum ODDS (%) | 4 days ago84% | 1 day ago83% |
MACD ODDS (%) | 1 day ago82% | 1 day ago77% |
TrendWeek ODDS (%) | 1 day ago85% | 1 day ago79% |
TrendMonth ODDS (%) | 1 day ago86% | 1 day ago80% |
Advances ODDS (%) | 4 days ago87% | 25 days ago82% |
Declines ODDS (%) | 17 days ago85% | 3 days ago82% |
BollingerBands ODDS (%) | N/A | 1 day ago70% |
Aroon ODDS (%) | 1 day ago83% | 1 day ago88% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
KBWR | 56.03 | N/A | N/A |
Invesco KBW Regional Banking ETF | |||
ARKW | 118.49 | N/A | N/A |
ARK Next Generation Internet ETF | |||
IBMQ | 25.16 | N/A | N/A |
iShares iBonds Dec 2028 Term Muni Bd ETF | |||
CVIE | 63.03 | N/A | N/A |
Calvert International Responsible ETF | |||
BMED | 23.75 | -0.05 | -0.23% |
iShares Health Innovation Active ETF |
A.I.dvisor indicates that over the last year, FLN has been loosely correlated with NU. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if FLN jumps, then NU could also see price increases.
Ticker / NAME | Correlation To FLN | 1D Price Change % | ||
---|---|---|---|---|
FLN | 100% | N/A | ||
NU - FLN | 50% Loosely correlated | N/A | ||
OMAB - FLN | 43% Loosely correlated | N/A | ||
PAGS - FLN | 37% Loosely correlated | +3.15% | ||
BAP - FLN | 36% Loosely correlated | +1.97% | ||
AC - FLN | 13% Poorly correlated | N/A | ||
More |